MarketCapExport financials
CHS (CHSCL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
CHS Balance Sheet 2026-2009 | CHSCL
Brief overview of CHS 's balance sheet strength
The balance sheet is assessed across five available annual reports spanning 2015 to 2019.
The asset base gained +8%, from $15.2 billion to $16.4 billion; average annual growth of 1.9% remained moderate.
Liabilities followed the scale of the balance sheet: +3.7% versus +8% for assets. Leverage did not change materially.
The equity-to-assets ratio is 52.3%, compared with 50.3% five periods ago. The balance sheet has a substantial internal cushion.
Net debt equals roughly 0.18x of equity. This is a moderate load and leaves room for maneuver.
The cash share moved from 6.3% to 1.3%. A higher figure generally provides more room in an adverse scenario.
Accumulated earnings ended at $1.6 billion, a change of -1.3%. They remain an important part of the capital base.
Overall assessment
CHS 's balance sheet is broadly resilient, though selected areas require monitoring. The balance between assets, equity and liabilities remains the key issue.
Annual Balance Sheet CHS
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.81 B | 1.53 B | 1.32 B | 15 M | 1.12 B | 1.17 B | 1.61 B | 1.58 B | 1.48 B | 2 B | 2.02 B | 477 M | -677 M | -202 M | 1.33 B | 762 M | - | - |
Long Term Debt |
2 B | 1.78 B | 2.12 B | 1.78 B | 1.91 B | 1.58 B | 1.75 B | 1.75 B | 1.76 B | 2.02 B | 2.09 B | 1.26 B | 1.3 B | 1.45 B | 1.33 B | 1.41 B | - | - |
Long Term Debt Current |
68.4 M | 70.8 M | - | - | - | - | - | - | - | - | - | - | 157 M | 157 M | 108 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | 2.25 B | 2.28 B | 2.64 B | 2.93 B | 2.3 B | 2.5 B | 2.57 B | 2.35 B | 1.99 B | - | - |
Total Current Liabilities |
5.61 B | 5.28 B | 5.4 B | 5.9 B | 6.95 B | 6.33 B | 4.92 B | 5.58 B | 5.93 B | 5.43 B | 6.52 B | 5.26 B | 6.18 B | 5.79 B | 6.6 B | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | 7.84 B | 8.22 B | 8.07 B | 9.45 B | 7.56 B | 8.68 B | 8.35 B | 8.95 B | 7.95 B | - | - |
Deferred Revenue |
195 M | 180 M | 249 M | 240 M | 542 M | 214 M | 139 M | 337 M | 546 M | 571 M | 622 M | 586 M | 868 M | 731 M | 1.49 B | 602 M | - | - |
Retained Earnings |
3.4 B | 3.02 B | 2.81 B | 2.54 B | 2.06 B | 1.71 B | 1.62 B | 1.58 B | 1.48 B | 1.47 B | 1.58 B | 1.6 B | 1.6 B | 1.38 B | 1.26 B | 1.08 B | - | - |
Total Assets |
20.1 B | 18.9 B | 18.7 B | 19 B | 18.8 B | 17.6 B | 16 B | 16.4 B | 16.4 B | 16 B | 17.3 B | 15.2 B | 15.1 B | 13.5 B | 13.4 B | 12.2 B | - | - |
Cash and Cash Equivalents |
264 M | 328 M | 795 M | 1.77 B | 794 M | 413 M | 141 M | 211 M | 451 M | 250 M | 279 M | 954 M | 2.13 B | 1.81 B | 314 M | 938 M | 395 M | 773 M |
Book Value |
20.1 B | 18.9 B | 18.7 B | 19 B | 18.8 B | 17.6 B | 16 B | 8.61 B | 8.17 B | 7.91 B | 7.87 B | 7.67 B | 6.47 B | 5.15 B | 4.47 B | 4.27 B | - | - |
Total Shareholders Equity |
11.6 B | 11.1 B | 10.8 B | 10.4 B | 9.46 B | 9.01 B | 8.81 B | 8.61 B | 8.16 B | 7.89 B | 7.85 B | 7.66 B | 6.45 B | 5.13 B | 4.46 B | 3.92 B | 3.6 B | 3.33 B |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet CHS
| 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
169 M | 1.98 B | 1.98 B | 1.74 B | 171 M | 1.83 B | 1.83 B | 1.82 B | 1.82 B | 1.67 B | 1.67 B | 1.82 B | 1.82 B | 1.81 B | 1.82 B | 1.67 B | 1.67 B | 1.8 B | 1.96 B | 1.58 B | 1.58 B | 208 M | 210 M | 198 M | 204 M | 206 M | 202 M | 204 M | 1.75 B | 1.75 B | 1.74 B | 1.74 B | 1.76 B | 1.91 B | 1.92 B | 1.94 B | 2.02 B | 2.05 B | 2.05 B | 1.96 B | 2.08 B | 2.41 B | 2.44 B | 1.23 B | 1.26 B | 1.17 B | 1.17 B | 1.21 B | 1.4 B | 1.31 B | 1.32 B | 1.34 B | 1.61 B | 1.3 B | 1.3 B | 1.3 B | 1.44 B | 1.39 B | 1.4 B | 1.38 B | 1.38 B | 1.41 B | 1.41 B | 1.38 B |
Deferred Revenue |
195 M | 286 M | 732 M | 202 M | 180 M | 274 M | 813 M | 266 M | 249 M | 282 M | 775 M | 268 M | 240 M | 318 M | 969 M | 367 M | 542 M | 545 M | 1.1 B | 420 M | 214 M | 319 M | 783 M | 184 M | 139 M | 205 M | 553 M | 205 M | 208 M | 183 M | 560 M | 188 M | 172 M | 172 M | 167 M | 178 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
3.4 B | 3.17 B | 2.98 B | 3.16 B | 3.02 B | 3.02 B | 2.83 B | 2.92 B | 2.81 B | 3.18 B | 2.98 B | 2.88 B | 2.54 B | 3.11 B | 2.71 B | 2.55 B | 2.06 B | 2.71 B | 2.2 B | 2.04 B | 1.71 B | 1.76 B | 1.51 B | 1.59 B | 1.62 B | 1.85 B | 1.74 B | 1.68 B | 1.58 B | 1.83 B | 1.79 B | 1.66 B | 1.48 B | 1.56 B | 1.45 B | 1.32 B | 1.27 B | 1.4 B | 1.56 B | 1.59 B | 1.58 B | 1.8 B | 1.7 B | 1.76 B | 1.49 B | 1.96 B | 1.87 B | 1.84 B | 1.6 B | 1.6 B | 1.6 B | 1.6 B | 1.38 B | 1.38 B | - | - | - | - | - | - | - | - | - | - |
Total Assets |
20.1 B | 20.8 B | 20.9 B | 20.7 B | 18.9 B | 19.7 B | 20.1 B | 19.6 B | 18.7 B | 18.5 B | 19.2 B | 20.4 B | 19 B | 19.2 B | 20.2 B | 21.1 B | 18.8 B | 20.7 B | 20.7 B | 19.6 B | 17.6 B | 18.6 B | 18.6 B | 18 B | 16 B | 16.8 B | 17 B | 17.2 B | 16.4 B | 17.6 B | 16.9 B | 16.9 B | 16.4 B | 16.7 B | 17 B | 16.6 B | 15.8 B | 17.1 B | 18.5 B | 18.3 B | 17.3 B | 18.3 B | 17.8 B | 16.5 B | 15.2 B | 15.9 B | 16.1 B | 16.7 B | 15.3 B | 14.9 B | 14.3 B | 14.6 B | 13.5 B | 13.1 B | 13.2 B | 14.3 B | 13.6 B | 11.5 B | 11.4 B | 12.1 B | 12.1 B | 12.2 B | 12.2 B | 12.1 B |
Cash and Cash Equivalents |
387 M | 611 M | 324 M | 458 M | 399 M | 404 M | 528 M | 535 M | 874 M | 390 M | 709 M | 1.42 B | 1.84 B | 1.07 B | 590 M | 744 M | 903 M | 540 M | 271 M | 459 M | 542 M | 419 M | 334 M | 240 M | 217 M | 484 M | 316 M | 272 M | 300 M | 255 M | 457 M | 342 M | 544 M | 581 M | 291 M | 343 M | 272 M | 267 M | 276 M | 517 M | 346 M | 346 M | 340 M | 1.26 B | 968 M | 1.1 B | 1.26 B | 1.67 B | 2.13 B | 1.55 B | 909 M | 2.14 B | 1.81 B | 734 M | 478 M | 1.16 B | 314 M | 689 M | 508 M | 1.8 B | 1.8 B | 938 M | 938 M | 1.8 B |
Book Value |
20.1 B | 20.8 B | 20.9 B | 20.7 B | 18.9 B | 19.7 B | 20.1 B | 19.6 B | 18.7 B | 18.5 B | 19.2 B | 20.4 B | 19 B | 19.2 B | 20.2 B | 21.1 B | 18.8 B | 20.7 B | 20.7 B | 19.6 B | 17.6 B | 18.6 B | 18.6 B | 18 B | 16 B | 16.8 B | 17 B | 17.2 B | 16.4 B | 17.6 B | 16.9 B | 16.9 B | 16.4 B | 16.7 B | 17 B | 16.6 B | 15.8 B | 17.1 B | 18.5 B | 18.3 B | 17.3 B | 18.3 B | 17.8 B | 16.5 B | 15.2 B | 15.9 B | 16.1 B | 16.7 B | 15.3 B | 14.9 B | 14.3 B | 14.6 B | 13.5 B | 13.1 B | 13.2 B | 14.3 B | 13.6 B | 11.5 B | 11.4 B | 12.1 B | 12.1 B | 12.2 B | 12.2 B | 12.1 B |
Total Shareholders Equity |
11.6 B | 11.2 B | 11.1 B | 11.2 B | 11.1 B | 10.8 B | 10.7 B | 10.8 B | 10.8 B | 10.9 B | 10.8 B | 10.7 B | 10.5 B | 10.1 B | 9.83 B | 9.73 B | 9.46 B | 9.74 B | 9.37 B | 9.25 B | 9.02 B | 8.95 B | 8.72 B | 8.79 B | 8.82 B | 8.78 B | 8.62 B | 8.62 B | 8.62 B | 8.41 B | 8.4 B | 8.29 B | 8.17 B | 7.92 B | 7.87 B | 7.74 B | 7.71 B | 7.68 B | 7.81 B | 7.82 B | 7.76 B | 7.87 B | 7.7 B | 7.8 B | 7.55 B | 7.72 B | 7.66 B | 7.16 B | 6.47 B | 6.32 B | 5.7 B | 5.56 B | 5.15 B | 5.01 B | 4.85 B | 4.69 B | 4.47 B | 4.38 B | 4.14 B | 4.08 B | 4.07 B | 4.46 B | 3.92 B | 4.07 B |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of CHS , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Argentina
Brasil
Mexico
Cayman-islands
China
Russia
Canada
